No Data
No Data
Investors Appear Satisfied With Stryker Corporation's (NYSE:SYK) Prospects
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 16x, you may consider Stryker Corporation (NYSE:SYK) as a stock to avoid entirely with its 37.6x
Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
Should You Investigate Stryker Corporation (NYSE:SYK) At US$334?
Stryker Is Maintained at Outperform by Evercore ISI Group
Stryker Is Maintained at Outperform by Evercore ISI Group
What 14 Analyst Ratings Have To Say About Stryker
Ratings for Stryker (NYSE:SYK) were provided by 14 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The following table encapsulates their recent ratings, offeri
Evercore ISI Group Maintains Outperform on Stryker, Lowers Price Target to $365
Evercore ISI Group analyst Vijay Kumar maintains Stryker with a Outperform and lowers the price target from $370 to $365.